Common Contracts
8 similar Cancer Research Grant Contract contracts by Bellicum Pharmaceuticals, Inc, ESSA Pharma Inc., Medicenna Therapeutics Corp., others
STATE OF TEXAS COUNTY OF TRAVISCancer Research Grant Contract • March 29th, 2024 • Molecular Templates, Inc. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Molecular Templates, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit in accordance with the rules of the Securities and Exchange Commission. DP220039 Andrew SimsCancer Research Grant Contract • September 22nd, 2022 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and PLUS Therapeutics, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY AND ACTUALLY TREATS THE INFORMATION AS PRIVATE OR CONFIDENTIAL.Cancer Research Grant Contract • June 22nd, 2022 • Medicenna Therapeutics Corp. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Medicenna Therapeutics, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
STATE OF TEXASCancer Research Grant Contract • November 5th, 2020 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Executive Director, and Bellicum Pharmaceuticals, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
STATE OF TEXAS COUNTY OF TRAVISCancer Research Grant Contract • November 7th, 2017 • Bellicum Pharmaceuticals, Inc • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Bellicum Pharmaceuticals, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
CANCER PREVENTION & RESEARCH INSTITUTE OF TAXESCancer Research Grant Contract • June 11th, 2015 • ESSA Pharma Inc. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and ESSA Pharma, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
CANCER PREVENTION & RESEARCH INSTITUTE OF TAXESCancer Research Grant Contract • February 24th, 2015 • ESSA Pharma Inc. • Pharmaceutical preparations • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and ESSA Pharma, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
STATE OF TEXAS COUNTY OF TRAVISCancer Research Grant Contract • June 17th, 2014 • Texas
This CANCER RESEARCH GRANT CONTRACT (“Contract”) is by and between the Cancer Prevention and Research Institute of Texas (“CPRIT”), hereinafter referred to as the “INSTITUTE”, acting through its Chief Executive Officer, and Medicenna Therapeutics, Inc., hereinafter referred to as the “RECIPIENT”, acting through its authorized signing official.
